Al-Quds University

Israel

Back to Profile

1-4 of 4 for Al-Quds University Sort by
Query
Aggregations
Jurisdiction
        World 2
        United States 1
        Canada 1
Date
2021 1
Before 2020 3
IPC Class
A61K 31/164 - Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides 2
C07C 235/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms 2
C07C 235/08 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms 2
C07C 271/16 - Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms 2
A61B 5/00 - Measuring for diagnostic purposes Identification of persons 1
See more
Status
Pending 1
Registered / In Force 3
Found results for  patents

1.

SYSTEMS AND METHODS FOR COGNITIVE DIAGNOSTICS FOR NEUROLOGICAL DISORDERS: PARKINSON'S DISEASE AND COMORBID DEPRESSION

      
Document Number 03157380
Status Pending
Filing Date 2020-10-08
Open to Public Date 2021-04-15
Owner
  • RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (USA)
  • AL-QUDS UNIVERSITY (Israel)
Inventor Herzallah, Mohammad

Abstract

A system for diagnosing a neurological disorder, Parkinson's Disease, and a comorbid mental health condition, major depressive disorder is provided. The system comprises a smart device and a device including a memory and a processor. The smart device allows a participant to perform a cognitive task and the device receives data collected from the smart device in connection with the cognitive task performed by the participant. The device determines whether the participant has Parkinson's Disease based on the data collected and via a classification algorithm. If the participant has Parkinson's Disease, the device determines whether the participant has comorbid major depressive disorder.

IPC Classes  ?

  • A61B 5/00 - Measuring for diagnostic purposes Identification of persons
  • A61B 5/16 - Devices for psychotechnicsTesting reaction times

2.

Compounds and methods of treating obesity

      
Application Number 14314228
Grant Number 09428448
Status In Force
Filing Date 2014-06-25
First Publication Date 2014-10-16
Grant Date 2016-08-30
Owner
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (Israel)
  • Al-Quds University (Israel)
Inventor
  • Katzhendler, Jehoshua
  • Saidian, Meir
  • Najajreh, Yousef
  • Mevorach, Raphael
  • Berry, Elliot
  • Avraham, Yosefa

Abstract

Provided are new fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, e.g., as agents for the treatment of obesity and related disorders, and for improving cognition.

IPC Classes  ?

  • A61K 31/164 - Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
  • A61K 31/325 - Carbamic acidsThiocarbamic acidsAnhydrides or salts thereof
  • C07C 235/28 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
  • C07C 233/91 - Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms
  • C07C 271/02 - Carbamic acidsSalts of carbamic acids
  • C07C 235/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
  • C07C 235/08 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
  • C07C 271/16 - Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
  • C07C 53/126 - Acids containing more than four carbon atoms
  • C07C 233/20 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
  • C07C 233/22 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
  • C07D 207/08 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms

3.

FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS

      
Application Number IL2013050618
Publication Number 2014/013497
Status In Force
Filing Date 2013-07-21
Publication Date 2014-01-23
Owner
  • YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Israel)
  • AL-QUDS UNIVERSITY (Israel)
Inventor
  • Berry, Elliot
  • Avraham, Yosefa
  • Katzhendler, Joshua
  • Mograbi, Josef
  • Najajreh, Yousef
  • Vorobeiv, Lia

Abstract

The invention provides fatty acid derivatives for use in a method of treatment of at least one disease, disorder or condition selected from anxiety, depression, conditions associated menopause, stress, bipolar disorder, neuropathic pain and fibromyalgia.

IPC Classes  ?

  • A61K 31/164 - Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
  • A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
  • A61P 25/22 - Anxiolytics
  • A61P 25/24 - Antidepressants
  • A61P 25/18 - Antipsychotics, i.e. neurolepticsDrugs for mania or schizophrenia
  • A61P 15/12 - Drugs for genital or sexual disordersContraceptives for climacteric disorders
  • A61P 25/20 - HypnoticsSedatives
  • A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
  • A61P 25/04 - Centrally acting analgesics, e.g. opioids

4.

COMPOUNDS AND METHODS OF TREATING OBESITY

      
Application Number IL2009000247
Publication Number 2009/109973
Status In Force
Filing Date 2009-03-04
Publication Date 2009-09-11
Owner
  • YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Israel)
  • AL-QUDS UNIVERSITY (Israel)
Inventor
  • Katzhendler, Jehoshua
  • Saidian, Meir
  • Najajreh, Yousef
  • Mevorach, Raphael
  • Berry, Elliot
  • Avraham, Yosefa

Abstract

The present invention relates to novel fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as agents for the treatment of obesity and related disorders, and for improving cognition.

IPC Classes  ?

  • C07C 235/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
  • C07C 271/16 - Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
  • A61K 31/27 - Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, e.g. meprobamate, carbachol, neostigmine
  • A61P 3/04 - AnorexiantsAntiobesity agents
  • C07C 235/08 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms